Literature DB >> 1972220

Nonsensus consensus.

P Skrabanek1.   

Abstract

Mesh:

Substances:

Year:  1990        PMID: 1972220     DOI: 10.1016/0140-6736(90)91460-r

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  A survey of undergraduate and continuing medical education about antimicrobial chemotherapy in the United Kingdom. British Society of Antimicrobial Chemotherapy Working Party on Antimicrobial Use.

Authors:  P Davey; S Hudson; G Ridgway; D Reeves
Journal:  Br J Clin Pharmacol       Date:  1993-12       Impact factor: 4.335

2.  Standards, guidelines and clinical policies.

Authors:  A M Clarfield
Journal:  CMAJ       Date:  1992-08-15       Impact factor: 8.262

Review 3.  Pharmacoeconomics of antibacterial treatment.

Authors:  P G Davey; M M Malek; S E Parker
Journal:  Pharmacoeconomics       Date:  1992-06       Impact factor: 4.981

4.  Rationing decisions: from diversity to consensus.

Authors:  L Schwartz; J Morrison; F Sullivan
Journal:  Health Care Anal       Date:  1999

5.  Setting up consensus standards for the care of patients in general practice.

Authors:  A Farmer
Journal:  Br J Gen Pract       Date:  1991-04       Impact factor: 5.386

Review 6.  Guidelines for the treatment of hypertension: a critical review.

Authors:  J I Robertson
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

7.  Development of guidelines for general practice care.

Authors:  R Grol
Journal:  Br J Gen Pract       Date:  1993-04       Impact factor: 5.386

8.  Practice guidelines and practical judgement: the role of mega-trials, meta-analysis and consensus.

Authors:  B G Charlton
Journal:  Br J Gen Pract       Date:  1994-07       Impact factor: 5.386

Review 9.  Role of ACE inhibitors in uncomplicated essential hypertension.

Authors:  J I Robertson
Journal:  Br Heart J       Date:  1994-09

10.  Reply to "Ten simple rules for getting published".

Authors:  Eric Grosch
Journal:  PLoS Comput Biol       Date:  2007-09       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.